The aim of this study was to compare the overall survival of a large, single-center cohort of
patients who had differentiated thyroid cancer (DTC) with that of a matched general …

Objectives The aim of this study is to identify the prognostic factors predicting remission and
subsequent disease relapse in patients with differentiated thyroid cancer (DTC) greater than …

Purpose We investigated whether age at diagnosis of differentiated thyroid carcinoma (DTC)
may be a risk factor for structural disease and mortality after primary treatment in aging …

Objective: Differentiated thyroid carcinoma (DTC) generally has a good prognosis. As yet,
however, it is unclear whether life expectancy is reduced in these patients and, if so, to what …

Background Differentiated thyroid carcinoma (DTC) shows a very good prognosis, but older
patients have a higher recurrence rate and those show poor prognosis than younger …

Background: In most staging systems, 45 years of age is used to differentiate low risk thyroid
cancer from high risk thyroid cancer. However, recent studies have questioned both the …

Background: The American Thyroid Association (ATA) uses criteria to assess the risk for
persistent disease in differentiated thyroid carcinoma (DTC) after radioiodine therapy (RAI) …

Differentiated thyroid carcinomas (DTC) have an excellent prognosis, with 10-year overall
survival rates over 90%. In addition, DTC patients benefit from their lifelong medical …

Differentiated thyroid cancer (DTC) has long been recognized as having a worse prognosis
in older people. We retrospectively evaluated the clinical and pathological characteristics of …

Objective The objectives of our study were to analyze the influence of age on the survival of
patients with RAIR-DTC and to determine their prognostic factors according to age. Methods …